Dividing groups of people into us and them isnt usually a good idea, but in the scary new world of COVID-19, it makes a certain sense. Issuing immunity licenses aka passports or certificates to people whose blood contains neutralizing antibodies against the novel coronavirus may be a safer way to reopen parts of the economy than letting unchecked crowds spill onto beaches, pack into subway cars, and fill eateries, stadiums, and concert venues.
Immunity licenses would give holders certain time-limited work and social freedoms, joining larger gatherings or returning to nonessential jobs, wrote Mark A. Hall, of the Wake Forest University Schools of Law and Medicine and David M. Studdert, from Stanford University Schools of Law and Medicine, in a recent Viewpoint in JAMA.
License holders could safely:
Getting an immunity license should be free. The Coronavirus Aid, Relief and Economic Security (CARES) Act requires private and public insurers to pay for all professional SARS-CoV-2 testing, including antibody tests, and reimburse hospitals for testing uninsured patients. And licenses wont be needed indefinitely. Theyre a bridge to gradually reawaken the economy until a combination of vaccines and recovery build towards herd immunity if that happens.
The coming of immunity licenses is almost inevitable, said Ezekiel Emanuel, an oncologist and bioethicist at the University of Pennsylvania during a webinar that JAMA held, upon publication of a Viewpointhe wrote with Govind Persad, from the University of Denver.
Countries like Chile and Germany have already said they would do this. If New Zealand becomes virus-free, theyre going to only want people coming in who can demonstrate a license or do a 14-day quarantine. The UK too is discussing an immunity-based license. Its going to be travel that forces the US to adopt the idea, Emanuel said.
On the surface, the idea of distinguishing those who have recovered from those who are susceptible to infection may seem like a ticket to discrimination, a literal status symbol. Would holding a license become part of a job application, a dating profile, a metro card, or a stamp on an airline ticket like TSA precheck?
More nefariously, would not having an immunity license become like wearing a scarlet letter as Hester Prynne did in Nathaniel Hawthornes classic tale to mark her as an adulteress, or Jewish people being forced to wear yellow starsin Nazi Germany?
Dr. Emanuel doesnt see it that way:
An immunity passport enhances the liberty of those people whove been exposed to and recovered from COVID-19, but it doesnt diminish the liberty of those who are nave to the virus.
But those not holding licenses might not agree.
Comparison to Nazi Germany, which Dr. Emanuel was asked about during the webinar, is a false dichotomy, he said. We have to recognize the difference between having a star because youre Jewish and having an immunity passport because youve recovered from COVID-19. The first is whats legally called invidious discrimination taking an irrelevant factor and excluding you from benefits and rights in society, and eventually sending you to concentration camps. Thats very different from an immunity passport not based on a characteristic like race, religion, or gender, but upon recovering from an infection and becoming immune so you cant pass it on.
Emanuel compared an immunity document to the necessity of having a drivers license. Driving a car poses a lethal threat to self and others. We test people, make distinctions in gradations you need a license to drive a bus or truck or motorcycle. Similarly, with an immunity passport, you get certified, but its time-limited because we dont know how long immunity will last. Natural immunity to SARS lasts up to 2 years and to MERSup to 3 years.
Widespread use of immunity licenses also depends upon having enough accurate serology testing to reliably detect neutralizing antibodies. And we still dont know whether reinfection happens.
In a report in Nature Medicine, Joshua Weitz, from the Georgia Institute of Technology, and his team coin the term shield immunity to describe using the short-term immunity of the recently-recovered to temporarily protect the vulnerable by replacing them in parts of the outside world.
Our epidemiological intervention computational model describes ways in which serological tests used to identify individuals who have been infected by and recovered from COVID-19 could help both reduce future transmission and foster increased economic engagement, said Weitz.
The model considers a population of a specific size against shielding strategies of varying strengths to predict number of lives saved. Strength refers to the proportion of protected individuals who substitute in society for infected individuals in a particular role such as recovered health care workers.
The metrics are clear. In a population of 10 million citizens, intermediate shielding with worst-case viral transmission can reduce 71,000 deaths to 58,000. But enhanced shielding more protected people replacing vulnerable ones would cut deaths down to 20,000.
Even better would be teaming shielding with continuing some social distancing as the economy reopens.
Documents similar to immunity licenses or passports are already in use. For example, students, teachers, and educational support staff need proof of vaccination to go to school. International travelrequires a slew of vaccinations. And of course health care workers need them.
But an immunity license for COVID-19 would differ from one for, say, yellow fever or hepatitis, in three ways, Hall and Studdert argued.
First, we know so little about the new virus compared to other pathogens. Secondly, immunity is possible only through infection and recovery, not also through a vaccine. People are vaccinated against yellow fever and hepatitis B, for example.
Thirdly, the conditioned privileges could include a greater range of fundamental civil liberties and opportunities, like freedom of association, worship, work, education, and travel, wrote Hall and Studdert.
As the idea of immunity licenses gains traction, some people are antsy about waiting for the particulars to be worked out. Knowing they were sick, some individuals might start going out more, assuming immunity even if theyd never had a diagnostic PCR-based test or one for protective antibodies. Wrote Hall and Studdert:
People will begin to self-certify, with much less accuracy and credibility than if certification were official. The rapidly unfolding situation raises a host of important legal, ethical, and policy concerns that will not wait for greater scientific certainty.
Emanuel agreed. Imagine being a parent of a child going to school, or hiring a nanny. Youd do your own immunity-based passport. If it starts out haphazardly, were not going to get an organized system, he warned.
I remember back in the 1960s, in that slice of time when youngsters progressed through a series of infectious diseases measles, mumps, rubella, and chickenpox many parents intentionally exposed their kids to sick friends to get the diseases over with. The practice of pox parties diminished when the public realized that these diseases can be deadly, and with the arrival of vaccines.
Physicians today fear coronavirus parties.
We are a society based on individual rights, and we want people to make choices about risk. We allow extreme sports, skiing, bungee jumping. We allow them to drive cars. We wont get rid of pox parties entirely, but we dont want to incentivize behavior that has serious complications, said Emanuel, who admitted to having had pox parties for his now-grown sons.
But the initial thinking that kids arent likely to contract or get very sick from COVID-19 has been changing. Young people can suffer strokes. And the recent emergence of multisystem inflammatory syndromein children weeks after the acute sickness, or even in asymptomatic kids, is a good reason not to intentionally expose a child.
The fact that the virus is affecting communities of color and povertyconsiderably more than other areas is undisputed. Reasons are many: access to health care, living in crowded conditions, higher prevalence of underlying conditions that elevate risk of infection. But these higher-risk groups may also disproportionately benefit from immunity licenses.
The licenses will actually correct some disparities and even operate more as a leveler than a class divider, said Hall and Studdert. That assumes antibody testing is available to all.
Emanuel offered an example. African-Americans are 45 to 50% of the Washington, DC population, but in terms of deaths from COVID-19, they account for around 80%. It is a horrible disparity. But immunity passports would then allow these African-Americans exposed to the virus to participate in employment. Theres no discrimination in an immunity-based passport. Its based on whether youve recovered or not.
Rolling out immunity licenses will also require safeguards. They must be hard to forge or counterfeit, a nonhackable electronic certification, said Emanuel, comparing the challenge to the FAA certifying pilots. States in the end will have this responsibility, he added.
Concludes Weitz, We dont have a silver bullet. Until we have a vaccine, we will have to use a combination of strategies to control COVID-19.
Ricki Lewis is the GLPs senior contributing writer focusing on gene therapy and gene editing. She has a PhD in genetics and is a genetic counselor, science writer and author of The Forever Fix: Gene Therapy and the Boy Who Saved It, the only popular book about gene therapy. BIO. Follow her at her website or Twitter @rickilewis
The rest is here:
- For cancer treatment and more, genetic-based precision medicine holds a lot of promise - Connecticut Magazine - May 31st, 2020
- Drug factories: GMOs and gene editing are poised to transform medicine. Here's how. - Genetic Literacy Project - May 31st, 2020
- How to know your risk factors for hypertension and whether high blood pressure is genetic - Insider - INSIDER - May 31st, 2020
- Venture capital found its footing in biotech. Then came the virus. - BioPharma Dive - May 31st, 2020
- Israeli Lab: Drugs For Gaucher Disease May Work Against Coronavirus, Other Viral Infections | Health News - NoCamels - Israeli Innovation News - May 31st, 2020
- Rapid Growth on Genetic Testing Market with COVID-19 Impact Analysis, Top Key Companies like Abbott Laboratories Bio-Rad Laboratories Inc.,... - May 31st, 2020
- insideHPC Special Report: HPC and AI for the Era of Genomics - insideHPC - May 31st, 2020
- More insight into the cytokine storm caused by Covid-19 could lead to a treatment - Health24 - May 31st, 2020
- UCalgary researchers launch 360-degree study of children and COVID-19 - UCalgary News - May 31st, 2020
- 4000 Years of contact, conflict and cultural change had little genetic impact in Near East - University of Birmingham - May 31st, 2020
- Precision Medicine Market Overview By Growing Demands, Trends And Business Opportunities 2020 To 2027 - Cole of Duty - May 31st, 2020
- NOT REAL NEWS: A look at what didn't happen this week - wausaupilotandreview.com - May 31st, 2020
- Precision Medicine Informs Cost-Effective Heart Disease Treatments - HealthITAnalytics.com - May 19th, 2020
- Colonizing Mars may require humanity to tweak its DNA - Space.com - May 19th, 2020
- Complement genes add to sex-based vulnerability in lupus and schizophrenia - Newswise - May 19th, 2020
- 23andMe Is Trying to Crack the Genetic Code Behind the Coronavirus - Motley Fool - May 19th, 2020
- Global Molecular Diagnostics Industry 2019-2029: Genetic Disorders, Cardiovascular Disorders, Infections and Cancer - Yahoo Finance UK - May 19th, 2020
- Prominent Cancer Researcher to Join DRI and Renown Health - GlobeNewswire - May 19th, 2020
- Research Roundup: HIV vaccination, diabetes two-in-one injection, hybrid fish genetics - The Stanford Daily - May 19th, 2020
- Singapore researches discover specific gene linked to Asian Lung Cancer - BSA bureau - May 19th, 2020
- Grant will help scientists break new ground in gene editing - Newswise - May 19th, 2020
- Genomic Medicine Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Ingersoll Rand, Johnson Controls, Daikin, United... - May 19th, 2020
- Dyne Therapeutics Accelerates Programs in Facioscapulohumeral Muscular Dystrophy (FSHD) with Exclusive Licensing of Technologies to Target Genetic... - May 19th, 2020
- New Stem Cell-Based Topical Solution Helps Bald People Regrow Hair - SciTechDaily - May 19th, 2020
- Scientists race to find a cure or vaccine for the coronavirus. Here are the top drugs in development - CNBC - May 19th, 2020
- WHITEHALL ANALYTICA THE AI SUPERSTATE: Part 2 Is COVID-19 Fast-Tracking a Eugenics-Inspired Genomics Programme in the NHS? - Byline Times - May 19th, 2020
- CRISPR And CRISPR-Associated (Cas) Genes Market Size, Share, Trends and Forecast 2026 by Major Players and Business Opportunities Caribou... - May 19th, 2020
- Researchers: Disease affecting kids could be in the genes - Newsday - May 19th, 2020
- From Competition To Sharing: How Her Childrens Rare Disease Led Sharon Terry To Revolutionize Medical Research - Forbes - May 9th, 2020
- Infection rates may have links to cancer - Medical News Today - May 9th, 2020
- Twin peeks: Stanford inherits twin registry, expanding research options - Stanford Medical Center Report - May 9th, 2020
- Management of Fertility and Hormonal Health in Women at Risk for Hereditary Gynecologic Cancers - Endocrinology Advisor - May 9th, 2020
- Individualized mosaics of microbial strains transfer from the maternal to the infant gut - Newswise - May 9th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 9th, 2020
- Its in your genes Whether Covid lands you in hospital or not depends on your body - ThePrint - May 9th, 2020
- FDA approves Tabrecta, first targeted therapy to treat metastatic NSCLC - The Cancer Letter - May 9th, 2020
- Research into the health of unborn babies receives government funding - UNSW Newsroom - May 9th, 2020
- Genetics and Weight: Is There an Obesity Gene? - LIVESTRONG.COM - May 9th, 2020
- New medical foundation invests in COVID-19 research funding - News - The University of Sydney - May 9th, 2020
- What Do Your Genetics Have to Do With Your Chances of Dying From Coronavirus? - Vanity Fair - May 3rd, 2020
- Scientists Find New Way to Inject Plants With Medicine, And It May Help Save Our Crops - ScienceAlert - May 3rd, 2020
- Sarepta Therapeutics Announces Research Agreement with US Department of Defense to Evaluate Multiple Constructs From its Proprietary RNA Platform as... - May 3rd, 2020
- Evanston hospitals expand to antibody testing - The Daily Northwestern - May 3rd, 2020
- Profits and Pride at Stake, the Race for a Vaccine Intensifies - The New York Times - May 3rd, 2020
- Data On Thousands Of Twins Reveals How Genetics Influences Covid-19 Symptoms - IFLScience - May 3rd, 2020
- The pieces of the puzzle of covid-19s origin are coming to light - The Economist - May 3rd, 2020
- LIST: UW awards $2.2 million to groups, scientists fighting the coronavirus in Wisconsin - WMTV - May 3rd, 2020
- World Laughter Day 2020: Why we must remember that laughter is indeed the best medicine - Hindustan Times - May 3rd, 2020
- When COVID-19 Mutates, What Are the Risks? - MedicineNet - May 3rd, 2020
- Facts that China is trying to suppress about origin of COVID-19 - WION - May 3rd, 2020
- COVID-19: What's RNA research got to do with it? - University of Rochester - May 3rd, 2020
- Medical, tech investments pay off in Covid-19 war - The Straits Times - May 3rd, 2020
- Welcome to the kingdom of the sick - Salon - May 3rd, 2020
- Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection - CMAJ - May 3rd, 2020
- XBiotech Identifies Super Bloods for the Development of a True Human COVID-19 Therapy - GlobeNewswire - May 3rd, 2020
- On National DNA Day, scientists are trying to take the colonialism out of genetics - Massive Science - April 26th, 2020
- Turning On the 'Off Switch' in Cancer Cells - Michigan Medicine - April 26th, 2020
- Turkey's top scientific body invests TL 2.3 billion on 16 vaccine projects over 5 years | Daily Sabah - Daily Sabah - April 26th, 2020
- Covid-19 will pass. What about the racism it has illuminated? - STAT - April 26th, 2020
- Infection Rate May Indicate a Future Diagnosis of Cancer - Cancer Network - April 26th, 2020
- Misleading coronavirus information falsely attributed to Johns Hopkins - AFP Factcheck - April 26th, 2020
- He signed up for a coronavirus vaccine trial using a method that's never been used in humans. Here's why. - CNN - April 26th, 2020
- New study could lead to therapeutic interventions to treat cocaine addiction - Newswise - April 26th, 2020
- As Cuomo Issues New Executive Order, Weill Cornell Medicine Ramps Up COVID-19 Testing - Cornell University The Cornell Daily Sun - April 26th, 2020
- Another Step Towards Earlier Detection of Pancreatic Cancer - MedPage Today - April 26th, 2020
- UW president, biochemistry chair and mathematics professor named to American Academy of Arts and Sciences - UW News - April 26th, 2020
- Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked... - April 26th, 2020
- Childhood Psychopathology Linked to Higher Levels of Genetic Vulnerability of Adult Depression - Clinical OMICs News - April 26th, 2020
- Gdask scientist makes crucial headway in understanding killer virus by isolating COVID-19 DNA from infected patient - The First News - April 26th, 2020
- Ethiopia's Ministry of Health Holds Webinar With Diaspora on COVID-19 Response at Tadias Magazine - Tadias Magazine - April 26th, 2020
- Immunity and our DNA: Why women are the stronger sex - The Age - April 26th, 2020
- Nobel laureate Luc Montagnier inaccurately claims that the novel coronavirus is man-made and contains genetic material from HIV - Health Feedback - April 26th, 2020
- Concert Genetics Presents Real-World Data on Utilization of NGS-Based Diagnostic Tests in NCCN 2020 Abstract - news-herald.net - April 2nd, 2020
- What scientists know about COVID-19 -- and what they don't - PBS NewsHour - April 2nd, 2020
- UVA Finds Way to Improve Cancer Outcomes by Examining Patients' Genes - University of Virginia - April 2nd, 2020
- Brown Alpert Medical School Autism Expert on Latest Advances in Research and Testing - GoLocalProv - April 2nd, 2020
- Coronavirus testing is ramping up. Here are the new tests and how they work. - Livescience.com - April 2nd, 2020
- Muscular Dystrophy Association Announces Formation of Strategic Medical Advisory Team of Experts in Neuromuscular Care and Research - PRNewswire - April 2nd, 2020
- Modalis Obtains Access to Foundational CRISPR IP - BioSpace - April 2nd, 2020
- Group behind NYC COVID-19 tent hospital is forcing medical workers to abide by anti-gay statement of faith - Metro Weekly - April 2nd, 2020